Hints and tips:
...Elaine Moore What kind of things are people discussing on r/AskHistorians? Sarah Gilbert History. (Chuckles) So r/AskHistorians is actually kind of new....
...The company is investing in an experimental plant laboratory at the farm and more R&D around pea varieties....
...Victoria Lebedeva-Baxter, Cambridge Finance for Normal People: How Investors and Markets Behave by Meir Statman....
...Ronny Gal, analyst at Bernstein, says: “Baxalta offers a rare opportunity of buying a commercial platform with decent exposure to rare diseases . . . with internal R&D capabilities and a pipeline for new...
...and BIA Board Keith Thompson CEO, Cell and Gene Therapy Catapult and BIA Board Dr Darrin Disley CEO and President, Horizon Discovery and BIA Board Dr Patrick Vallance President, Pharmaceuticals R&...
...Innovative Medicines and Early Development, AstraZeneca Steve Bates Chief Executive, BioIndustry Association Harpal Kumar Chief Executive, Cancer Research UK Patrick Vallance President of Pharmaceuticals R&...
...R....
...GlaxoSmithKline and Baxter have long had significant R&D presences in Wallonia, surrounded by homegrown forces such as UCB, a biopharma company that focuses on diseases affecting the nervous and immune systems...
...One-third of the sector’s workforce, for example, is employed in R&D activities, but this proportion increases substantially when the sample is restricted to SMEs....
...affairs director at the company and active in a number of the region’s professional organisations, says his parent company invests €600m ($823m) a year in Belgium, split between production and continued R&...
...John R....
...In this edited transcript, Adrian Allen, one of the AMRC’s founders and its commercial director, talks about the role of the centre in the region and beyond, in an interview with Andrew Baxter, senior writer...
...Baxter is using its protein stabilisation technology for haemophilia and woundcare products....
...Moving to the park, and benefiting from synergies in bringing sales and R&D together, was, he says, a “no-brainer”....
...Film Von Sternberg, by John Baxter, University Press of Kentucky RRP£25 The ego has landed....
...A GSK spokesperson said ophthalmology is an area that the company has recently moved into in early R&D – a development that has sparked M&A interest among the investment banking community....
...border, he says, it has opened up enormously in the past 30 years – something he should know about since, as well as being club secretary, he is chief executive of the game’s governing body, known as The R&...
...This pushed the company, which has designed outdoor lamps for camping gear company Coleman and portable blood donation systems for US healthcare company Baxter, to open its first overseas office this month...
...If the average age of the scientists in your company’s R&D department is 48, surely there is no need to worry yet about losing expertise if one of them retires?...
...“Also, as a software company, we have high R&D costs and very low manufacturing costs – our product isn’t even put in a box. So it costs no more to make another one.”...
...Pharmaceutical companies such as Bristol-Myers Squibb and chemical companies such as Dow Chemical and W.R.Grace are among big customers for Polycom’s integrated approach....
...Aujla Director, Empress Building Centre Sir Anthony Bamford Chairman, JCB Martin Barrow Director, Matheson Co Neville Baxter Chairman, RH Group Nick Beart Director, Moyses Stevens Ahsok Bhagani Partner,...
International Edition